Skip to main content

Advertisement

SpringerLink
Log in

Therapeutic lifestyle change and adult treatment panel III: Evidence then and now

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

The Third Report of the National Cholesterol Education Program’s Adult Treatment Panel (ATP III) has an extensive section on nonpharmacologic therapy for those with abnormal blood lipids. ATP III focused on the high-saturated fat atherogenic diet, obesity, and sedentary lifestyle and recommended a program of therapeutic lifestyle change (TLC). This review discusses several issues, including 1) why ATP III changed from the Step I and Step II diets to TLC; 2) the benefits of keeping trans fatty acid intake low and the addition of viscous fiber and plant stanol/sterol esters to reduce low-density lipoprotein cholesterol beyond that seen with the Step II diet; 3) the de-emphasis on total fat and a sharper focus on the kinds of fat ingested in the new guidelines; 4) the endorsement of regular physical activity and weight loss as important first steps in reversing the unwanted metabolic effects of the metabolic syndrome; and 5) the emphasis of health-promoting aspects of the diet that include, among other things, fish and omega-3 fatty acids. At all stages of TLC, ATP III encourages the referral to registered dietitians or other qualified nutritionists for medical nutrition therapy. TLC and the ATP III guidelines should provide guidance to practitioners who wish to get low-density lipoprotein cholesterol to goal (whether or not drugs are used), prevent or treat the metabolic syndrome, and improve the overall health of the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).JAMA 2001, 285:2486.

  2. Stone NJ, Blum C: Management of Lipids in Clinical Practice, edn 4. Cado, Oklahoma: Professional Communications; 2002.

    Google Scholar 

  3. Yu-Poth S, Zhao G, Etherton T, et al.: Effects of the National Cholesterol Education Program’s Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 1999, 69:632–646.

    PubMed  CAS  Google Scholar 

  4. Walden CE, Retzlaff BM, Buck BL, McCann BS, Knopp RH: Lipoprotein lipid response to the National Cholesterol Education Program step II diet by hypercholesterolemic and combined hyperlipidemic women and men. Arterioscler Thromb Vasc Biol 1997, 17:375–382.

    PubMed  CAS  Google Scholar 

  5. Ginsberg HN, Kris-Etherton P, Dennis B, Elmer PJ, et al., for the Delta Research Group: Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects. The Delta Study, Protocol 1. Arterioscler Thromb Vasc Biol 1998, 18:441–449.

    PubMed  CAS  Google Scholar 

  6. Niinikoski H, Lapinleimu H, Viikari J, et al.: Growth until three years of age in a prospective randomized trial of a diet with reduced saturated fat and cholesterol. Pediatrics 1997, 99:687–694.

    Article  PubMed  CAS  Google Scholar 

  7. Obarzanek E, Hunsberger SA, Van Horn L, et al.: Safety of a fat-reduced diet: the Dietary Intervention Study in Children (DISC). Pediatrics 1997, 100:51–59.

    Article  PubMed  CAS  Google Scholar 

  8. Sun Z, Welty FK, Dolnikowski GG, Lichtenstein AH, Schaefer EJ: Effects of a National Cholesterol Education Program Step II Diet on apolipoprotein A-IV metabolism within triacylglycerol-rich lipoproteins and plasma. Am J Clin Nutr 2001, 74:308–314.

    PubMed  CAS  Google Scholar 

  9. Gordon DJ: Cholesterol and mortality: what can meta-analysis tell us. In Cardiovascular Disease 2: Cellular and Molecular Mechanisms, Prevention, and Treatment. Edited by Gallo LL. New York: Plenum Press; 1995:333–340.

    Google Scholar 

  10. Gordon DJ: Cholesterol lowering and total mortality. In Lowering Cholesterol in High-risk Individuals and Populations. Edited by Rifkind BM. New York: Marcel Dekker; 1995:33–47.

    Google Scholar 

  11. Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD: Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation 1998, 97:946–952.

    PubMed  CAS  Google Scholar 

  12. Brousseau ME, Schaefer EJ: Diet and coronary heart disease: clinical trials. Curr Atheroscler Rep 2000, 2:487–493.

    PubMed  CAS  Google Scholar 

  13. Watts GF, Lewis B, Brunt JN, et al.: Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas’ Atherosclerosis Regression Study (STARS). Lancet 1992, 339:563–569.

    Article  PubMed  CAS  Google Scholar 

  14. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, et al.: Efficacy of a National Cholesterol Education Program Step 2 diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and women. Arterioscler Thromb Vasc Biol 1995, 15:1079–1085.

    PubMed  CAS  Google Scholar 

  15. Knopp RH, Walden CE, Retzlaff BM, et al.: Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men. The Dietary Alternatives Study. JAMA 1997, 278:1509–1515.

    Article  PubMed  CAS  Google Scholar 

  16. Knopp RH, Retzlaff B, Walden C, et al.: One-year effects of increasingly fat-restricted, carbohydrate-enriched diets on lipoprotein levels in free-living subjects. Proc Soc Exp Biol Med 2000, 225:191–199.

    Article  PubMed  CAS  Google Scholar 

  17. Velez-Carrasco W, Lichtenstein AH, Welty FK, et al.: Dietary restriction of saturated fat and cholesterol decreases HDL apoA-I secretion. Arterioscler Thromb Vasc Biol 1999, 19:918–924.

    PubMed  CAS  Google Scholar 

  18. Stefanick ML, Mackey S, Sheehan M, et al.: Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med 1998, 339:12–20.

    Article  PubMed  CAS  Google Scholar 

  19. Caggiula AW, Christakis G, Farrand M, et al.: The Multiple Risk Intervention Trial (MRFIT). IV. Intervention on blood lipids. Prev Med 1981, 10:443.

    Article  PubMed  CAS  Google Scholar 

  20. Stamler J, Shekelle R: Dietary cholesterol and human coronary heart disease. The epidemiologic evidence. Arch Pathol Lab Med 1988, 112:1032–1040.

    PubMed  CAS  Google Scholar 

  21. Lichtenstein AH, Ausman LM, Jalbert SM, Schaefer EJ: Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 1999, 340:1933–1940.

    Article  PubMed  CAS  Google Scholar 

  22. Hu FB, Stampfer MJ, Manson JE, et al.: Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr 1999, 70:1001–1008.

    PubMed  CAS  Google Scholar 

  23. Kromhout D, Menotti A, Bloemberg BP, et al.: Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 1995, 24:308–315.

    Article  PubMed  CAS  Google Scholar 

  24. Pietinen P, Ascherio A, Korhonen P, et al.: Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 1997, 145:876–887.

    PubMed  CAS  Google Scholar 

  25. Willett WC, Stampfer MJ, Manson JE, et al.: Intake of trans-fatty acids and risk of coronary heart disease among women. Lancet 1993, 341:581–585.

    Article  PubMed  CAS  Google Scholar 

  26. Han SN, Leka LS, Lichtenstein AH, et al.: Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res 2002, 43:445–452.

    PubMed  CAS  Google Scholar 

  27. Hopkins PN: Effects of dietary cholesterol on serum cholesterol: a meta-analysis and review. Am J Clin Nutr 1992, 55:1060–1070.

    PubMed  CAS  Google Scholar 

  28. Clarke R, Frost C, Collins R, Appleby P, Peto R: Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997, 314:112–117.

    PubMed  CAS  Google Scholar 

  29. Ernst ND, Sempos CT, Briefel RR, Clark MB: Consistency between U.S. dietary fat intake and serum total cholesterol concentrations: the National Health and Nutrition Examination Surveys. Am J Clin Nutr 1997, 66(suppl 4):965S-972S.

    PubMed  CAS  Google Scholar 

  30. Tippett KS, Cleveland LE: How current diets stack up: comparison with dietary guidelines. In America’s Eating Habits: Changes and Consequences. Washington, DC: United States Department of Agriculture, Economic Research Service; 2000:51–70.

    Google Scholar 

  31. Weggemans RM, Zock PL, Ordovas JM, Ramos-Galluzzi J, Katan MB: Genetic polymorphisms and lipid response to dietary changes in humans. Eur J Clin Invest 2001, 31:950–957.

    Article  PubMed  CAS  Google Scholar 

  32. Hu FB, Stampfer MJ, Rimm EB, et al.: A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA 1999, 281:1387–1394.

    Article  PubMed  CAS  Google Scholar 

  33. Weggemans RM, Zock PL, Katan MB: Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: a meta-analysis. Am J Clin Nutr 2001, 73:885–891.

    PubMed  CAS  Google Scholar 

  34. Anderson JW, Hanna TJ: Impact of nondigestible carbohydrates on serum lipoproteins and risk for cardiovascular disease. J Nutr 1999, 129:1457S-1466S.

    PubMed  CAS  Google Scholar 

  35. Meyer KA, Kushi LH, Jacobs DR Jr, et al.: Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 2000, 71:921–930.

    PubMed  CAS  Google Scholar 

  36. Brown L, Rosner B, Willett WW, Sacks FM: Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999, 69:30–42.

    PubMed  CAS  Google Scholar 

  37. Hunninghake DB, Miller VT, LaRosa JC, et al.: Hypocholesterolemic effects of a dietary fiber supplement. Am J Clin Nutr 1994, 59:1050–1054.

    PubMed  CAS  Google Scholar 

  38. Ludwig DS, Pereira MA, Kroenke CH, et al.: Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA 1999, 282:1539–1546.

    Article  PubMed  CAS  Google Scholar 

  39. Hallikainen MA, Sarkkinen ES, Gylling H, Erkkila AT, Uusitupa MI: Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr 2000, 54:715–725.

    Article  PubMed  CAS  Google Scholar 

  40. Westrate JA, Meijer GW: Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1998, 52:334–343.

    Article  Google Scholar 

  41. Blair SN, Capuzzi DM, Gottlieb SO, et al.: Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol 2000, 86:46–52.

    Article  PubMed  CAS  Google Scholar 

  42. Law M: Plant sterol and stanol margarines and health. BMJ 2000, 320:861–864.

    Article  PubMed  CAS  Google Scholar 

  43. Noakes M, Clifton P, Ntanios F, et al.: An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. Am J Clin Nutr 2002, 75:79–86.

    PubMed  CAS  Google Scholar 

  44. Reaven G: Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 2002, 106:286–288.

    Article  PubMed  Google Scholar 

  45. Zock PL: Dietary fats and cancer. Curr Opin Lipidol 2001, 12:5–10.

    Article  PubMed  CAS  Google Scholar 

  46. Holmes MD, Hunter DJ, Colditz GA, et al.: Association of dietary intake of fat and fatty acids with risk of breast cancer. JAMA 1999, 281:914–920.

    Article  PubMed  CAS  Google Scholar 

  47. Rose DP: Dietary fatty acids and cancer. Am J Clin Nutr 1997, 66(suppl 4):998S-1003S.

    PubMed  CAS  Google Scholar 

  48. Heitmann BL, Lissner L, Sorensen TI, Bengtsson C: Dietary fat intake and weight gain in women genetically predisposed for obesity. Am J Clin Nutr 1995, 61:1213–1217.

    PubMed  CAS  Google Scholar 

  49. Lissner L, Heitmann BL: The dietary fat: carbohydrate ratio in relation to body weight. Curr Opin Lipidol 1995, 6:8–13.

    Article  PubMed  CAS  Google Scholar 

  50. Hirsch J, Hudgins LC, Leibel RL, Rosenbaum M: Diet composition and energy balance in humans. Am J Clin Nutr 1998, 67(suppl 3):551S-555S.

    PubMed  CAS  Google Scholar 

  51. Leibel RL, Hirsch J, Appel BE, Checani GC: Energy intake required to maintain body weight is not affected by wide variation in diet composition. Am J Clin Nutr 1992, 55:350–355.

    PubMed  CAS  Google Scholar 

  52. Garg A: High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 1998, 67(suppl 3):577S-582S.

    PubMed  CAS  Google Scholar 

  53. Chen YD, Coulston AM, Zhou MY, Hollenbeck CB, Reaven GM: Why do low-fat high-carbohydrate diets accentuate postprandial lipemia in patients with NIDDM? Diabetes Care 1995, 18:10–16.

    Article  PubMed  CAS  Google Scholar 

  54. Grundy SM: Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med 1986, 314:745–748.

    Article  PubMed  CAS  Google Scholar 

  55. Mensink RP, Katan MB: Effect of monounsaturated fatty acids versus complex carbohydrates on high-density lipoproteins in healthy men and women. Lancet 1987, 1:122–125.

    Article  PubMed  CAS  Google Scholar 

  56. Mensink RP, Katan MB: Effects of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992, 12:911–9.

    PubMed  CAS  Google Scholar 

  57. Garg A: High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 1998, 67(suppl 3):577S-582S.

    PubMed  CAS  Google Scholar 

  58. Kris-Etherton PM, Kris-Etherton PM, Binkoski AE, et al.: Dietary fat: assessing the evidence in support of a moderate-fat diet; the benchmark based on lipoprotein metabolism. Proc Nutr Soc 2002, 61:287–298.

    Article  PubMed  CAS  Google Scholar 

  59. Verschuren WM, Jacobs DR, Bloemberg BP, et al.: Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 1995, 274:131–136.

    Article  PubMed  CAS  Google Scholar 

  60. Fraser GE, Sabate J, Beeson WL, Strahan TM: A possible protective effect of nut consumption on risk of coronary heart disease: the Adventist Health Study. Arch Intern Med 1992, 152:1416–1424.

    Article  PubMed  CAS  Google Scholar 

  61. Hu FB, Stampfer MJ, Manson JE, et al.: Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. BMJ 1998, 317:1341–1345.

    PubMed  CAS  Google Scholar 

  62. Gardner CD, Kraemer HC: Monounsaturated versus polyunsaturated dietary fat and serum lipids A meta-analysis. Arterioscler Thromb Vasc Biol 1995, 15:1917–1927.

    PubMed  CAS  Google Scholar 

  63. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico.Lancet 1999, 354:447–455.

  64. Jenkins DJ, Wolever TM, Rao AV, et al.: Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol. N Engl J Med 1993, 329:21–26.

    Article  PubMed  CAS  Google Scholar 

  65. Turley ML, Skeaff CM, Mann JI, Cox B: The effect of a low-fat, high-carbohydrate diet on serum high density lipoprotein cholesterol and triglyceride. Eur J Clin Nutr 1998, 52:728–732.

    Article  PubMed  CAS  Google Scholar 

  66. Vuksan V, Sievenpiper JL, Owen R, et al.: Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care 2000, 23:9–14.

    Article  PubMed  CAS  Google Scholar 

  67. Liu S, Willett WC, Stampfer MJ, et al.: A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr 2000, 71:1455–1461.

    PubMed  CAS  Google Scholar 

  68. Liu S, Manson JE, Stampfer MJ, et al.: Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. Am J Clin Nutr 2001, 73:560–566.

    PubMed  CAS  Google Scholar 

  69. Levin RJ: Carbohydrates. In Modern Nutrition in Health and Disease, edn 9. Edited by Shils ME, Olson JA, Shine M, Ross AC. Baltimore: Williams and Wilkins; 1999:63–64.

    Google Scholar 

  70. Foster-Powell K, Holt SH, Brand-Miller JC: International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 2002, 76:5–56.

    PubMed  CAS  Google Scholar 

  71. Su HY, Sheu WH, Chin HM, et al.: Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals. Am J Hypertens 1995, 8:1067–1071.

    Article  PubMed  CAS  Google Scholar 

  72. Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393–403.

    Article  PubMed  CAS  Google Scholar 

  73. Tuomilehto J, Lindstrom J, Eriksson JG, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343–1350.

    Article  PubMed  CAS  Google Scholar 

  74. Kris-Etherton P, Eckel RH, Howard BV, St. Jeor S, Bazzarre TL: AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation 2001, 103:1823–1825.

    PubMed  CAS  Google Scholar 

  75. de Lorgeril M, Salen P, Martin JL, et al.: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarctioin: final report of the Lyon Diet Heart Study. Circulation 1999, 99:779–785.

    PubMed  Google Scholar 

  76. Roche HM, Gibney MJ: Effects of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. Am J Clin Nutr 2000, 71:232S-237S.

    PubMed  CAS  Google Scholar 

  77. Harris WS: Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 1989, 30:785–807.

    PubMed  CAS  Google Scholar 

  78. Harris WS: n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997, 65(suppl 5):1645–1654.

    Google Scholar 

  79. Albert CM, Hennekens CH, O’Donnell CJ, et al.: Fish consumption and risk of sudden cardiac death. JAMA 1998, 279:23–28.

    Article  PubMed  CAS  Google Scholar 

  80. Daviglus ML, Stamler J, Orencia AJ, et al.: Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997, 336:1046–1053.

    Article  PubMed  CAS  Google Scholar 

  81. Dolecek TA, Granditis G: Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet 1991, 66:205–216.

    PubMed  CAS  Google Scholar 

  82. Morris MC, Manson JE, Rosner B, et al.: Fish consumption and cardiovascular disease in the Physicians’ Health Study: a prospective study. Am J Epidemiol 1995, 142:166–175.

    PubMed  CAS  Google Scholar 

  83. Ascherio A, Katan MB, Zock PL, Stampfer MJ, Willett WC: Trans fatty acids and coronary heart disease. N Engl J Med 1999, 340:1994–1998.

    Article  PubMed  CAS  Google Scholar 

  84. Kannel WB, Schatzkin A: Sudden death: lessons from subsets in population studies. J Am Coll Cardiol 1985, 5(suppl 6):141B-149B.

    Article  PubMed  CAS  Google Scholar 

  85. Albert CM, Campos H, Stampfer MJ, et al.: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002, 346:1113–1118.

    Article  PubMed  CAS  Google Scholar 

  86. Guallar E, Hennekens CH, Sacks FM, Willett WC, Stampfer MJ: A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol 1995, 25:387–394.

    Article  PubMed  CAS  Google Scholar 

  87. Siscovick DS, Raghunathan TE, King I, et al.: Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995, 274:1363–1367.

    Article  PubMed  CAS  Google Scholar 

  88. Burr ML, Fehily AM, Gilbert JF, et al.: Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet 1989, 2:757–761.

    Article  PubMed  CAS  Google Scholar 

  89. Singh RB, Niaz MA, Sharma JP, et al.: Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival—4. Cardiovasc Drugs Ther 1997, 11:485–491.

    Article  PubMed  CAS  Google Scholar 

  90. Marchioli R, Barzi F, Bomba E, et al.: Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105:1897–1903.

    Article  PubMed  CAS  Google Scholar 

  91. Leaf A: On the reanalysis of the GISSI-Prevenzione. Circulation 2002, 105:1874–1875.

    Article  PubMed  Google Scholar 

  92. Rissanen T, Voutilainen S, Nyyssonen K, Lakka TA, Salonen JR: Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation 2000, 102:2677–2679.

    PubMed  CAS  Google Scholar 

  93. Sacks FM, Stone PH, Gibson CM, et al.: Controlled trial of fish oil for regression of human coronary atherosclerosis. J Am Coll Cardiol 1995, 25:1492–1498.

    Article  PubMed  CAS  Google Scholar 

  94. von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H: The Effect of dietary n-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999, 130:554–562.

    Google Scholar 

  95. Leaf A, Jorgensen MB, Jacobs AK, et al.: Do fish oils prevent restenosis after coronary angioplasty? Circulation 1994, 90:2248–2257.

    PubMed  CAS  Google Scholar 

  96. Physical Activity and Health: a Report of the Surgeon General. U.S. Department of Health and Human Services. McLean, VA: International Medical Publishing; 1996.

  97. Blackburn DG: Establishing an effective framework for physical activity counseling in primary care settings. Nutr Clin Care 2002, 5:95–102.

    Article  PubMed  Google Scholar 

  98. Schwenk TL, Chenoweth J, Carter R, et al.: A multisite field test of the acceptability of physical activity counseling in primary care: project PACE. Am J Prev Med 1996, 12:73–81.

    PubMed  Google Scholar 

  99. US Preventive Services Task Force: Behavioral counseling in primary care to promote physical activity: recommendations and rationale. Ann Intern Med 2002, 137:205–207.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine and Preventive Medicine, Feinberg School of Medicine of Northwestern University, 211 East Chicago Avenue, Suite 1050, 60611, Chicago, IL, USA

    Neil J. Stone MD & Linda Van Horn PhD, RD

Authors
  1. Neil J. Stone MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Linda Van Horn PhD, RD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stone, N.J., Van Horn, L. Therapeutic lifestyle change and adult treatment panel III: Evidence then and now. Curr Atheroscler Rep 4, 433–443 (2002). https://doi.org/10.1007/s11883-002-0047-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-002-0047-x

Keywords

Search

Navigation